M

Murni Sadar Tbk PT
IDX:MTMH

Watchlist Manager
Murni Sadar Tbk PT
IDX:MTMH
Watchlist
Price: 990 IDR -1.49% Market Closed
Market Cap: Rp2T

Murni Sadar Tbk PT
Other

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Murni Sadar Tbk PT
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
M
Murni Sadar Tbk PT
IDX:MTMH
Other
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Siloam International Hospitals Tbk PT
IDX:SILO
Other
Rp9.2B
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medikaloka Hermina Tbk PT
IDX:HEAL
Other
-Rp43.7B
CAGR 3-Years
-16%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Metro Healthcare Indonesia Tbk PT
IDX:CARE
Other
-Rp1.7B
CAGR 3-Years
N/A
CAGR 5-Years
48%
CAGR 10-Years
N/A
S
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
Other
-Rp453.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-25%
Mitra Keluarga Karyasehat Tbk PT
IDX:MIKA
Other
-Rp16.6B
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Murni Sadar Tbk PT
Glance View

Market Cap
2T IDR
Industry
Health Care

PT Murni Sadar Tbk engages in the ownership and operation of hospitals and medical centers through its subsidiaries. The company is headquartered in Medan, Sumatera Utara and currently employs 2,237 full-time employees. The company went IPO on 2022-04-20. Its facilities and services include outpatient installation, laboratory, radiotherapy, radiology, heart and vascular center, endoscopy, medic rehabilitation, general service, intensive care, general facility and others. The Company’s subsidiaries include PT Murni Sadar Kasih Abadi, PT Sahid Sahirman Memorial Hospital, PT Medikarya Aminah Utama, and PT Rumah Sakit Ibu dan Anak Rosiva.

MTMH Intrinsic Value
1 195.9 IDR
Undervaluation 17%
Intrinsic Value
Price Rp990
M

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett